Strides Pharma Science Q3 Results

  • BSE: 532531
  • NSE: STAR
  • ISIN: INE939A01011
  • Sector: Biotechnology & Drugs
BSE
1,419.15-84.60 (-5.63%)
Volume17.28 K
Updated: Mon 25 Nov, 2024 | 15:47:42
NSE
1,417.45-86.80 (-5.77%)
Volume5.63 L
Updated: Mon 25 Nov, 2024 | 15:44:11
Today: 1,394.05
1,529.80
52-Wk: 482.50
1,675.25

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Strides Pharma Science Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ CompDec 22YoY Comp
    Total Revenue 1,037.67999.43-%864.85-%
    Selling/ General/ Admin Expenses Total 184.49199.93-%181.01-%
    Depreciation/ Amortization 51.2360.10-%60.22-%
    Other Operating Expenses Total 238.12228.28-%200.00-%
    Total Operating Expense 905.151,071.33-%767.16-%
    Operating Income 132.52-71.91-%97.68-%
    Net Income Before Taxes 10.01-156.90-%-78.02-%
    Net Income 49.67-131.34-%-80.03-%
    Diluted Normalized EPS 0.23-2.67-%-11.85-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts